美国 · SEC FORM 4
ADC Therapeutics SA
ADCT · NYSE · CIK 0001771910 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
18 同一窗口内观察到的 Form 4 交易行
0 sales · 18 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号?
评分构成
活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数?
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。
卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后,这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-12-11 · Green Jeremy; RedCo II Master Fund, L.P.; Redmile Group, LLC.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -6.8%
- 3M
- -8.9%
- 6M
- -66.5%
- 12M
- -69.1%
波动率与流动性
- 波动率
- 106.7%
- Beta
- 1.86
- 平均每日成交额
- USD 1.7M
估值
- 市值
- USD 157.0M
- P/E
- —
基本面
- 利润率
- -175.3%
- ROE
- —
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至:2026-10-05 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率 · 财年截止日:2025-12-31 · 来自 Yahoo Finance:市值 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 6,896,051
- 上期报告
- 5,390,567
- 日均成交量
- 1,579,045
- 回补天数
- 4.4
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-12-11 | Green Jeremy; RedCo II Master Fund, L.P.; Redmile Group, LLC | 买入 (P) | Common Shares, par value CHF 0.08 per share | 100,000 | USD 3.04 | USD 304,500 | SEC 申报 ↗ |
| 2024-07-01 | Green Jeremy; RedCo II Master Fund, L.P.; Redmile Group, LLC | 买入 (P) | Common Shares, par value CHF 0.08 per share | 400,000 | USD 2.81 | USD 1,124,000 | SEC 申报 ↗ |
Form 4 申报证据
37 transaction lines in the latest 365-day window; 83 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Zaki Mohamed | 奖励/授予 (A) | Common Shares | 213,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-30 | MALLIK AMEET | 奖励/授予 (A) | Common Shares | 675,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-30 | GRAHAM PETER J | 奖励/授予 (A) | Common Shares | 221,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Zaki Mohamed | 奖励/授予 (A) | Common Shares | 213,900 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-30 | MALLIK AMEET | 奖励/授予 (A) | Common Shares | 675,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-30 | GRAHAM PETER J | 奖励/授予 (A) | Common Shares | 221,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-30 | Carmona Jose | 奖励/授予 (A) | Common Shares | 203,700 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-03 | Squarer Ron | 代扣税 (F) | Common Shares | 15,196 | USD 3.08 | USD 46,804 | SEC 申报 ↗ |
| 2026-06-03 | Sandor Victor | 代扣税 (F) | Common Shares | 12,600 | USD 3.08 | USD 38,808 | SEC 申报 ↗ |
| 2026-06-03 | Monges Viviane | 代扣税 (F) | Common Shares | 2,596 | USD 3.08 | USD 7,996 | SEC 申报 ↗ |
| 2026-06-03 | Hug Peter | 代扣税 (F) | Common Shares | 2,156 | USD 3.08 | USD 6,640 | SEC 申报 ↗ |
| 2026-06-03 | Coughlin Timothy | 代扣税 (F) | Common Shares | 12,600 | USD 3.08 | USD 38,808 | SEC 申报 ↗ |
| 2026-06-03 | BIZZARI JEAN-PIERRE | 代扣税 (F) | Common Shares | 12,600 | USD 3.08 | USD 38,808 | SEC 申报 ↗ |
| 2026-06-03 | Azelby Robert | 代扣税 (F) | Common Shares | 12,600 | USD 3.08 | USD 38,808 | SEC 申报 ↗ |
| 2026-06-01 | Squarer Ron | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Sandor Victor | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Monges Viviane | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Hug Peter | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Coughlin Timothy | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | BIZZARI JEAN-PIERRE | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | Azelby Robert | 奖励/授予 (A) | Common Shares | 45,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-04-02 | Green Jeremy; RedCo II Master Fund, L.P.; Redmile Group, LLC | 卖出 (S) | Common Stock | 5,163,997 | USD 3.28 | USD 16,937,910 | SEC 申报 ↗ |
| 2026-04-01 | Green Jeremy; RedCo II Master Fund, L.P.; Redmile Group, LLC | 卖出 (S) | Common Stock | 331,782 | USD 3.80 | USD 1,260,772 | SEC 申报 ↗ |
| 2026-02-13 | Zaki Mohamed | 代扣税 (F) | Common Shares | 24,603 | USD 3.99 | USD 98,166 | SEC 申报 ↗ |
| 2026-02-13 | Zaki Mohamed | 奖励/授予 (A) | Common Shares | 285,200 | USD 3.99 | USD 1,137,948 | SEC 申报 ↗ |
| 2026-02-13 | MALLIK AMEET | 代扣税 (F) | Common Shares | 103,231 | USD 3.99 | USD 411,892 | SEC 申报 ↗ |
| 2026-02-13 | MALLIK AMEET | 奖励/授予 (A) | Common Shares | 900,000 | USD 3.99 | USD 3,591,000 | SEC 申报 ↗ |
| 2026-02-13 | Kallebo Lisa Michelle | 代扣税 (F) | Common Shares | 5,433 | USD 3.99 | USD 21,678 | SEC 申报 ↗ |
| 2026-02-13 | Kallebo Lisa Michelle | 奖励/授予 (A) | Common Shares | 62,900 | USD 3.99 | USD 250,971 | SEC 申报 ↗ |
| 2026-02-13 | GRAHAM PETER J | 代扣税 (F) | Common Shares | 33,294 | USD 3.99 | USD 132,843 | SEC 申报 ↗ |
| 2026-02-13 | GRAHAM PETER J | 奖励/授予 (A) | Common Shares | 294,800 | USD 3.99 | USD 1,176,252 | SEC 申报 ↗ |
| 2026-02-13 | Carmona Jose | 代扣税 (F) | Common Shares | 25,880 | USD 3.99 | USD 103,261 | SEC 申报 ↗ |
| 2026-02-13 | Carmona Jose | 奖励/授予 (A) | Common Shares | 271,600 | USD 3.99 | USD 1,083,684 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ADCT |
| CIK | 0001771910 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 83 transaction lines from 2024-05-07 to 2026-06-30 3 P purchase lines · 13 S sale lines · 67 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.